.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Pulmonary arterial hypertension (PAH) involves complex vascular remodeling and metabolic changes. Recent research highlights how TAGLN2 expression in PAH acts as a critical driver of the disease. By utilizing Mendelian randomization, scientists have uncovered a causal link between the Transgelin 2 (TAGLN2) gene and increased disease risk. Furthermore, they found that epigenetic factors significantly influence this pathway.
DNA methylation plays a pivotal role in governing gene activity without altering the underlying sequence. Specifically, the study identified two methylation sites—cg13892570 and cg16107628—that regulate how the TAGLN2 gene is transcribed. Notably, these sites mediate the effect of TAGLN2 expression on PAH by over 86%. Consequently, this suggests that therapeutic strategies targeting DNA methylation could potentially mitigate disease progression.
To validate these genetic findings, researchers examined lung tissues from a monocrotaline (MCT)-induced rat model. The results demonstrated that TAGLN2 mRNA was significantly upregulated in affected lung tissues. Therefore, TAGLN2 emerges as a promising biomarker for diagnosis and a potential target for personalized medicine. In addition, the study reinforces the importance of succinylation-related genes in vascular health. Clinicians may find these insights useful for understanding the molecular drivers of pulmonary vascular resistance.
TAGLN2 expression in PAH promotes vascular remodeling, which increases pulmonary artery pressure. It acts as an actin-binding protein that influences the behavior of smooth muscle cells.
DNA methylation serves as an epigenetic switch that controls the transcription of the TAGLN2 gene. High levels of specific methylation can drive the overexpression of this disease-causing gene.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a substitute for professional healthcare guidance. Always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Chen Z et al. DNA Methylation-Mediated Regulation of TAGLN2 Expression Promotes Pulmonary Arterial Hypertension. Arch Med Res. 2026 May 14. doi: undefined. PMID: 42134034.
Grover V, et al. The emerging role of epigenetics in pulmonary arterial hypertension. PMC. 2015.
Archer SL, et al. Epigenetic mechanisms of pulmonary hypertension. PMC. 2012.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research identifies TAGLN2 as a causal driver of pulmonary arterial hypertension, regulated by DNA methylation, revealing new targets for therapy....
3 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
